Association of Psychiatric Illness and Obesity, Physical Inactivity, and Smoking among a National Sample of Veterans

Psychosomatics

Volumn 52, Issue 3, 2011, Pages 230-236

  Chwastiak, Lydia A ^a   Rosenheck, Robert A ^b   Kazis, Lewis E ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; BIPOLAR DISORDER; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HEALTH BEHAVIOR; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBESITY; PHYSICAL ACTIVITY; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SMOKING; TOBACCO; VETERAN; MENTAL DISEASE; MIDDLE AGED; MOTOR ACTIVITY; PSYCHOLOGICAL ASPECT; RISK FACTOR; SEDENTARY LIFESTYLE; STATISTICAL MODEL; STATISTICS; UNITED STATES;

CHI T I ALLERGEN; HEMOGLOBIN; INSECT PROTEIN;

BIPOLAR DISORDER; COMORBIDITY; FEMALE; HEALTH BEHAVIOR; HEMOGLOBINS; HUMANS; INSECT PROTEINS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; RISK FACTORS; SCHIZOPHRENIA; SEDENTARY LIFESTYLE; SMOKING; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES; VETERANS;

EID: 80052886652     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2010.12.009     Document Type: Article

References (41)

1. Enger C., Weatherby L., Reynolds R.F., et al. Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis 2004, 192:19-27.
2. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?. Arch Gen Psychiatry 2007, 64:1123-1131.
3. Lespérance F., Frasure-Smith N., Talajic M., et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002, 105:1049-1053.
4. Roshanaei-Moghaddam B., Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: A review. Psychiatr Serv 2009, 60:147-156.
5. Boscarino J.A. A prospective study of PTSD and early-age heart disease mortality among Vietnam veterans: Implications for surveillance and prevention. Psychosom Med 2008, 70:668-676.
6. Carney R.M., Blumenthal J.A., Freedland K.E., et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005, 165:1486-1491.
7. Otte C., Neylan T.C., Pipkin S.S., et al. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: Findings from the Heart and Soul Study. Am J Psychiatry 2005, 162:2139-2145.
8. Otte C., Marmar C.R., Pipkin S.S., et al. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul study. Biol Psychiatry 2004, 56:241-247.
9. Frasure-Smith N., Lesperance F., Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 2004, 55:891-896.
10. Newcomer J.W. Antipsychotic medications: Metabolic and cardiovascular risk. J Clin Psychiatry 2007, 68(Suppl 4):8-13.
11. Stahl S.M., Mignon L., Meyer J.M. Which comes first: Atypical antipsychotic treatment or cardiometabolic risk?. Acta Psychiatr Scand 2009, 119:171-179.
12. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
13. Kreyenbuhl J., Dickerson F.B., Medoff D.R., et al. Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. J Nerv Ment Dis 2006, 194:404-410.
14. Druss B.G., Bradford D.W., Rosenheck R.A., et al. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000, 283:506-511.
15. Shroufi A., Powles J.W. Adherence and chemoprevention in major cardiovascular disease: A simulation study of the benefits of additional use of statins. J Epidemiol Community Health 2010, 64:109-113.
16. Dolder C.R., Furtek K., Lacro J.P., et al. Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness. Psychosomatics 2005, 46:135-141.
17. Diet, smoking and cardiovascular risk in people with schizophrenia. Br J Psychiatry 2003, 183:534-539. McCreadie RG on behalf of the Scottish Schizophrenia Lifestyle Group.
18. Osborn D.P.J., Nazareth I., King M.B. Physical activity, dietary habits, and coronary heart disease risk factor knowledge amongst people with severe mental illness. Soc Psychiatry Psychiatr Epidemiol 2007, 42:787-793.
19. Ziegelstein R.C., Fauerbach J.A., Stevens S.S., et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000, 160:1818-1823.
20. Ziedonis D., Hitsman B., Beckham J.C., et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 2008, 10:1691-1715.
21. Roick C., Fritz-Wieacker A., Matschinger H., et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2007, 42:268-276.
22. Steinberg M.L., Ziedonis D.M., Krejci J.A., et al. Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. J Consult Clin Psychol 2004, 72:723-728.
23. Wu R.R., Zhao J.P., Jin H., et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: A randomized controlled trial. JAMA 2008, 299:185-193.
24. Jean-Baptiste M., Tek C., Liskov E., et al. A pilot study of a weight management program with food provision in schizophrenia. Schizophr Res 2007, 96:198-205.
25. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
26. Kazis L.E., Selim A., Rogers W., et al. Dissemination of methods and results from the Veterans Health Study: Final comments and implications for future monitoring strategies within and outside the Veterans Health Care System. J Ambulatory Care Management 2006, 29:4310-4319.
27. International Classification of Diseases, 9th Revision, Clinical Modification. (ICD-9-CM) 2007, US Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics, Hyattsville, MD.
28. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998, (Suppl2):51S-209S. NHLBI Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults.
29. Physical status: The use and interpretation of anthropometry: Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995, 854:1-452. World Health Organization.
30. Skinner K.M., Miller D.R., Lincoln E., et al. Concordance between respondent self-reports and medical records for chronic conditions: Experience from the Veterans Health Study. J Ambul Care Manage 2005, 28(2):102-110.
31. Chwastiak L.A., Rosenheck R.A., Kazis L.E. Utilization of primary care by veterans with psychiatric illness in the National Department of Veterans Affairs Health Care System. J Gen Intern Med 2008, 23:1835-1840.
32. Davis S., Malarcher A., Thorne S., et al. State-Specific Prevalence and Trends in Adult Cigarette Smoking-United States, 1998-2007. JAMA 2009, 302:250-252. Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion CDC.
33. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
34. Haskell W.L., Lee I.M., Pate R.R., et al. Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association: Physical activity and public health. Circulation 2007, 116:1081-1093.
35. Whooley M.A., de Jonge P., Vittinghoff E., et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300:2379-2388.
36. Cunningham C.O., Sohler N.L., Wong M.D., et al. Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care STDS 2007, 21:177-186.
37. Kroenke K., Spitzer R.L., Williams J.B., et al. Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317-325.
38. Elgar F.J., Stewart J.M. Validity of self-report screening for overweight and obesity. Evidence from the Canadian Community Health Survey. Can J Public Health 2008, 99:423-427.
39. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
40. Miller D.R., Klaman D., Ren X.S., et al. Health behaviors of Veterans in the VHA: Nutrition and Physical Activity, 1999 Large Health Survey of VHA enrollees April 2002, Office of Quality and Performance (OQP-10Q), Washington DC.
41. McFall M., Atkins D.C., Yoshimoto D., et al. Integrating tobacco cessation treatment into mental health care for patients with posttraumatic stress disorder. Am J Addict 2006, 15:336-344.